Visit Thermo Fisher for more information and education on Procalcitonin.
Procalcitonin (PCT) is a biomarker of bacterial infection that aids in the risk assessment of critically ill patients and can be used to de-escalate antibiotic therapy. Procalcitonin recently became available on a variety of analytical platforms making it accessible to more laboratories. This webinar reviews the utility of PCT and describes a team based approach to implementing this biomarker in clinical practice.
What you will learn
- The clinical utility of PCT for differentiating bacterial from viral infections
- The clinical utility of PCT for de-escalating antibiotic therapy in respiratory infections
- How to develop a plan for implementing PCT in their clinical practice
Robert L. Fitzgerald, PhD, DABCC
Director of Toxicology
Associate Director of Clinical Chemistry
University of California-San Diego Health
*Please ensure you have the most up to date version of your web browser to avoid a technical error during registration.